Effectiveness and safety of a New Standardised TrEatment Protocol based on initial/early therapy with single-pill combinations of blood pressure-lowering drugs for improving blood pressure control (NewSTeP): Rationale, design of a randomized clinical trial and baseline characteristics of the trial participants
medRxiv
Abstract
BackgroundHypertension is the leading modifiable risk factor for cardiovascular disease (CVD). Despite availability of blood pressure (BP)-lowering therapies, BP control rates remain suboptimal. Reluctance to initiate treatment with combination therapy and delayed treatment intensification contribute to poor control.
The paper
Rupasvi Dhurjati, Rashmi Pant, Amit Kumar, Abdul Salam
Show 19 more authors
Anshika Mittal, Krishnaiah Chappidi, Gautam Satheesh, Parul Puri, Sasi Kumar Tiruttani, Shwetha Rajaram, Aneesh Basheer, Prabhdeep Kaur, Andrew Moran, Andrés Rosende, Poongothai Subramani, Sandeep Mahajan, Nupur Lalvani, Sandeep Bansal, Dorairaj Prabhakaran, Jayagopal Pathiyil Balagopalan, Stephen Jan, Mark D. Huffman, Vivekanand Jha,George Institute for Global Health · Manipal Academy of Higher Education
medRxiv · 11 Sep 2026 · CC BY · Preprint, not peer-reviewed
